ALINAMIN, created in 2012 (Japan), from 440 sister brands and 4958 competing brands. ALINAMIN is a brand of Takeda Pharmaceutical, listed on the stock exchange of Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. ALINAMIN belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(ALINAMIN)
over 5 years*
EUR 18.90